OT possesses anti-secretory and anti-ulcer effects, facilitates wound healing and is involved in the modulation of immune and inflammatory processes by targeting OTR, which provides a new opportunity to improve the clinical management of IBS, IBD and other GI disorders without compromising the immune system. This evidence concerns the gene OXTR and irritable bowel syndrome.